Some providers do adjust maintenance doses based on response
Mechanism of action: Activates both GLP-1 receptors AND GIP (glucose-dependent insulinotropic polypeptide) receptors simultaneously GIP receptors in fat tissue directly regulate lipid metabolism and fat cell energy storage Dual activation creates a synergistic effect on appetite suppression and energy expenditure Produces stronger improvement in insulin sensitivity compared to GLP-1-only medications FDA-approved brand names: Zepbound approved for chronic weight management Mounjaro approved for type 2 diabetes Why does the dual mechanism matter
With no taste interference, it's the invisible boost your diet deserves
However, some people dont experience a significant difference in their appetite while on semaglutide therapy
A: Common side effects include nausea, vomiting, diarrhea, and injection site reactions
Yang J, Luo L, Zhao C, Li X, Wang Z, Zeng Z, et al